Contact usLogin

Dalfampridine

Uses

Dalfampridine is used in the treatment of multiple sclerosis (MS). It helps improve walking ability and walking speed in individuals with multiple sclerosis.

How it Works

How Dalfampridine works Dalfampridine is a potassium channel blocker that enhances communication between nerves and muscles. This improvement leads to increased muscle activity, specifically walking, in individuals with multiple sclerosis.

Side Effects

Common side effects of Dalfampridine include influenza, viral infection, anxiety, vertigo, palpitations, breathlessness, and vomiting.

Expert Advice

  • Dalfampridine helps improve walking in adults with multiple sclerosis.
  • It may take 2-6 weeks for the medication to start working.
  • Continue taking it as prescribed.
  • Do not chew, cut, or crush the tablet, as this may result in the release of too much medication into your body at once.
  • Inform your doctor if you have a history of seizures or kidney problems.

Other Combinations

Frequently asked questions

Is Dalfampridine an immunosuppressant?
Dalfampridine is not an immunosuppressant; it is used to treat multiple sclerosis by enhancing nerve conduction in damaged neurons and can improve walking speed in patients.
Who should avoid taking Dalfampridine?
Patients with kidney issues, those allergic to Dalfampridine, or individuals with a history of seizures should avoid this medication. Always consult your doctor before starting treatment.
What is the correct way to take Dalfampridine?
Take Dalfampridine exactly as prescribed, typically one tablet twice daily, about 12 hours apart, with or without food. Swallow the tablet whole; do not break, crush, or chew.
What is the proper way to store Dalfampridine?
Store Dalfampridine at 15ºC to 30ºC in its original packaging to protect it from light and moisture. Do not use after the expiry date and keep it out of children's reach.
How long does it take for Dalfampridine to start working?
Dalfampridine may take a few weeks to show improvement, and its effectiveness varies based on the patient's condition severity and response. Regular weekly monitoring is recommended during treatment, and consult your doctor for specific guidance.
;